Clinical trial Recruiting at 1 site Interventional Ages 16 to 25

Low-intensity blood flow restriction training to improve leg strength and kicking in taekwondo athletes

Official title: Effects of Low-Intensity Blood Flow Restriction Training on Lower-Limb Strength and Kicking Performance in Taekwondo Athletes: A Randomized Controlled Trial

Run by Shanghai University of Sport · NCT07538037 · Data updated 2026-11-12

This project will test if low-intensity blood flow restriction during workouts can help national-level taekwondo athletes (aged 16–25) improve lower-limb strength and kicking performance.

Quick facts

Study typeInterventional
Ages16 Years to 25 Years
SexAll
Enrollment18 (estimated)
SponsorShanghai University of Sport
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedApril 10, 2026
Main results expectedJune 29, 2026
Study endsJune 29, 2026
Registry record updatedApril 20, 2026
Trial IDNCT07538037 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

National-level taekwondo athletes aged 16–25 with at least 3 years of systematic training, no lower-limb injury in the past 6 months, and no major cardiovascular, metabolic, or neurological disorders are ideal candidates.

Probably not a fit

Individuals with current lower-limb injuries, relevant medical conditions, or those not meeting the required training background are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants are randomized to a low-intensity blood flow restriction training (LI-BFRT) group or a conventional high-intensity resistance training (HIRT) group and complete a supervised 6-week lower-limb program three times per week. LI-BFRT uses controlled external limb occlusion to create a hypoxic, metabolically stressful environment while using lower mechanical loads. The HIRT group performs traditional high-load resistance exercises without occlusion. Outcomes include measures of lower-limb strength, explosive performance, and sport-specific kicking ability to compare the training effects between approaches.

Why it matters

Potential benefit: If successful, athletes could achieve similar strength and kicking gains using lower mechanical loads, potentially reducing joint stress and training burden.

How similar studies have gone: Previous research shows LI-BFRT often produces strength and hypertrophy comparable to high-load training in various populations, but sport-specific evidence in taekwondo is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Taekwondo athletes aged 16-25 years National-level athletes (National Level 1 or higher); Minimum of 3 years of systematic taekwondo training experience; Free from lower-limb injury within the past 6 months; Able to complete the training intervention and testing procedures.

Exclusion Criteria:

\- History of cardiovascular, metabolic, or neurological disorders; Current musculoskeletal injury or pain affecting training; Participation in other structured resistance training programs during the study period; Use of medications or supplements that may affect physical performance Inability or unwillingness to provide informed consent.

Where it's running

  • Shanghai University of Sport
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.